Related Experiment Video

Updated: Oct 28, 2026

Subcutaneous Infection of Methicillin Resistant Staphylococcus Aureus (MRSA)
12:18

Subcutaneous Infection of Methicillin Resistant Staphylococcus Aureus (MRSA)

Published on: February 9, 2011

[A study of virulence factors produced by MRSA strains isolated from blood samples]

R Mizukane1, M Nakatomi, Y Futsuki

  • 1Internal Medicine, National Nagasaki Hospital.

Kansenshogaku Zasshi. the Journal of the Japanese Association for Infectious Diseases
|October 22, 1998
PubMed

Insights

Toxic shock syndrome toxin-1 (TSST-1) and enterotoxins are key virulence factors in Staphylococcus aureus infections. Higher toxin production in MRSA strains from blood indicates potential for severe disease, informing prevention and treatment strategies.

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Clinical Science

Context:

  • Staphylococcus aureus, particularly Methicillin-resistant Staphylococcus aureus (MRSA), produces toxins like Toxic Shock Syndrome Toxin-1 (TSST-1) and enterotoxins.
  • These toxins are recognized as critical virulence factors associated with severe conditions such as septic shock and toxic shock syndrome.
  • Understanding the prevalence and patterns of toxin production in clinical MRSA isolates is crucial for managing infections.

Purpose:

  • To investigate the production of TSST-1 and enterotoxins in MRSA strains.
  • To analyze the correlation between toxin production and coagulase types in MRSA isolates.
  • To compare toxin production frequencies across different sample sources (blood, urine, pharynx).

Summary:

  • A study of 701 MRSA strains from Sasebo City General Hospital (1994-1996) revealed TSST-1 or/and enterotoxins in 67% of isolates.
  • Toxin production, including both TSST-1 and enterotoxin C, was significantly higher in MRSA strains isolated from blood samples (88%) compared to urine and pharyngeal samples.
  • Specifically, 45% of all strains and 70% of blood isolates produced both TSST-1 and enterotoxin C, with significant differences noted between blood and pharyngeal isolates (p < 0.05).

Impact:

  • The findings highlight the significant role of TSST-1 and enterotoxins as MRSA virulence factors, particularly in bloodstream infections.
  • Identifying specific toxin profiles in MRSA isolates can provide valuable information for targeted prevention and treatment strategies.
  • This research contributes to a better understanding of MRSA pathogenesis and informs clinical decision-making for severe staphylococcal infections.

More Related Videos

A Fluorescence-based Method to Study Bacterial Gene Regulation in Infected Tissues07:10

A Fluorescence-based Method to Study Bacterial Gene Regulation in Infected Tissues

Published on: February 19, 2019

Related Concept Videos

Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Determinants of Bacterial Pathogenicity and Virulence01:20

Determinants of Bacterial Pathogenicity and Virulence

Pathogenic bacteria employ a variety of strategies to establish infections, including the secretion of extracellular enzymes that act as potent virulence factors. These enzymes facilitate bacterial colonization of host tissues and help evade immune surveillance. By targeting structural components of host tissues and interfering with immune mechanisms, these enzymes play a pivotal role in disease progression.Extracellular Enzymes Facilitating Tissue Invasion: Several bacterial pathogens secrete...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Staphylococcal Skin Infections01:29

Staphylococcal Skin Infections

Staphylococcus aureus is a Gram-positive coccus that resides harmlessly on the skin and mucous membranes of healthy individuals. When the skin barrier is breached, it can shift from a commensal to an opportunistic pathogen. This transition is facilitated by surface adhesins, such as clumping factor B and S. aureus surface protein G (SasG), which bind to structural proteins, including loricrin and cytokeratin, in the damaged epidermis. Protein A, another key factor, binds the Fc region of...
Regulation of Bacterial Virulence01:28

Regulation of Bacterial Virulence

Pathogenic bacteria employ a range of regulatory mechanisms to modulate the expression of virulence genes in response to environmental and host-derived signals. These mechanisms ensure that virulence factors are expressed only under favorable conditions, thereby optimizing infection and survival strategies.Mechanisms of Virulence RegulationKey regulatory strategies include:Two-Component Systems: These consist of a membrane-bound sensor kinase and a cytoplasmic response regulator. Environmental...